Naderi G, Latif A, Karimi S, Tabassomi F, Esfahani S T
Department of Kidney Transplantation, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Department of General Surgery, Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Int J Organ Transplant Med. 2017;8(2):85-96. Epub 2017 May 1.
Kidney transplantation is the optimal treatment for end-stage renal disease in children. However, long-term graft survival has not significantly improved among pediatric patients.
To investigate the determinants of long-term graft survival among Iranian pediatric recipients of kidney transplantation.
In a single-center cohort study, we studied 314 pediatric kidney transplantations performed from 1989 to 2013 at Dr. Shariati Hospital, Tehran, Iran. Different variables were collected for each patient and graft survival rates were calculated.
After a mean±SD follow-up period of 15.8±4.0 years, the mean±SD graft survival rate was 14.5±0.5 years; the 1-, 5-, 10-, and 20-year mean graft survival rates were 90%, 81%, 62%, and 62%, respectively. The corresponding patient survival rates were 100%, 99.4%, 97.8%, and 96.5%, respectively. Pre-emptive transplantation (p=0.006), and living graft donation (p=0.002) led to higher graft survival, while acute rejection (p=0.002), and primary disease of primary hyperoxaluria (p=0.001) led to lower graft survival. Chronic rejection was the most frequent cause of graft loss.
Short-term graft survival still outpaces the long-term outcome. Modifying the mentioned determinants, with more intense immunosuppression for greater prevention of acute and chronic rejection, and increased rate of pre-emptive transplantation and living donor transplantation, long-term graft survival may significantly improve in future.
肾移植是儿童终末期肾病的最佳治疗方法。然而,儿科患者的长期移植肾存活率并未显著提高。
探讨伊朗儿科肾移植受者长期移植肾存活的决定因素。
在一项单中心队列研究中,我们研究了1989年至2013年在伊朗德黑兰沙里亚蒂医院进行的314例儿科肾移植手术。收集了每位患者的不同变量,并计算了移植肾存活率。
在平均±标准差为15.8±4.0年的随访期后,平均±标准差的移植肾存活率为14.5±0.5年;1年、5年、10年和20年的平均移植肾存活率分别为90%、81%、62%和62%。相应的患者存活率分别为100%、99.4%、97.8%和96.5%。抢先移植(p=0.006)和活体移植供肾(p=0.002)导致更高的移植肾存活率,而急性排斥反应(p=0.002)和原发性高草酸尿症的原发性疾病(p=0.001)导致更低的移植肾存活率。慢性排斥反应是移植肾丢失的最常见原因。
短期移植肾存活率仍高于长期结果。通过调整上述决定因素,加强免疫抑制以更好地预防急性和慢性排斥反应,提高抢先移植和活体供肾移植的比例,未来长期移植肾存活率可能会显著提高。